ISM

For U.S. residents only ages 18+

ISM

AdvSM

PDGFRA GIST

woman sitting at a table using a laptop

Frequently Asked Questions (FAQs)

Real Patient

Real Patient

Frequently Asked Questions (FAQs)

ISM FAQs

Systemic mastocytosis (SM) is a rare disorder in which excess abnormal mast cells build up in the body. Mast cells are a type of white blood cell that helps the immune system function normally and helps protect from disease. Mast cells are found in connective tissues throughout the body. In SM, a surplus of abnormal mast cells collects in the skin, bone marrow, digestive tract, or other body organs. When triggered, these excess abnormal mast cells release histamines and other chemicals that can cause symptoms similar to those that occur in an allergic reaction, as well as inflammation that may be severe enough to result in organ damage. 

ISM is a rare disease that affects the production and accumulation of abnormal mast cells, a type of white blood cell. Normally, your body makes mast cells as part of your immune response, but a buildup of abnormal mast cells in different parts of the body can lead to symptoms similar to severe allergic reactions.

SM is a rare blood disorder characterized by a build up of abnormal mast cells in the bone marrow and other organs. As an indolent, non-advanced form of SM, ISM usually has less build up of abnormal mast cells compared to advanced forms of SM.

However, people with ISM may have serious symptoms that could affect various organs, including potentially life-threatening anaphylaxis.

For most people, ISM is caused by a change (or mutation) in a gene known as the KIT D816V gene mutation. This gene mutation plays a role in the development of mast cells.

No, you do not need to have the KIT D816V gene mutation to be prescribed AYVAKIT.

ISM is diagnosed by a doctor who may measure signs of excess mast cells by:

  • Performing a tryptase test. A doctor will draw blood from your arm to measure the amount of tryptase (an enzyme that is released by mast cells) in your blood.
  • Taking biopsies. Biopsies are tissue samples taken for closer examination. Organ and/or bone marrow biopsies are used to measure the number of mast cells within tissue and to detect abnormalities.
  • Testing for KIT D816V gene mutation. There are different types of KIT tests available that vary in sensitivity. High-sensitivity tests may be required to detect the mutation.

Each patient with ISM may experience different symptoms in different ways. Various symptoms are associated with ISM, including:

  • Brain fog
  • Dizziness
  • Headache
  • Fatigue
  • Flushing
  • Bone pain
  • Itching
  • Spots on the skin
  • Abdominal pain
  • Diarrhea
  • Nausea

Across all types, systemic mastocytosis is estimated to occur in about 1 out of every 10,000 people—with ISM representing 75-90% of those cases.

AYVAKIT FAQs

Once you’ve been prescribed AYVAKIT, your doctor sends your prescription to an eligible pharmacy or to YourBlueprint®. The pharmacy will verify your insurance coverage and work directly with your healthcare provider to obtain prior authorization if needed. Then, when coverage is approved, your pharmacy will contact you to communicate your out-of-pocket costs and arrange for delivery or pickup of your medication.

Over 99% of all commercial insurance plans and 99% of Medicare plans offer coverage for AYVAKIT.*

*Data on coverage and co-pay assistance is as of December 2023. Cost-sharing data is for those patients with commercial insurance.

Yes. YourBlueprint® offers financial assistance options to help qualifying patients get on and stay on treatment.

icon representing an envelope

Want more information about AYVAKIT?

INDICATION

WHAT IS AYVAKIT® (avapritinib)?

AYVAKIT® (avapritinib) is a prescription medicine used to treat adults with indolent systemic mastocytosis (ISM). AYVAKIT is not recommended in people with low platelet counts (less than 50 X 109/L). It is not known if AYVAKIT is safe and effective in children.

IMPORTANT SAFETY INFORMATION

AYVAKIT® (avapritinib) may cause serious side effects, including:

Cognitive effects. Cognitive side effects can happen during treatment with AYVAKIT and can be severe. Tell your healthcare provider if you develop any new or worsening cognitive symptoms including forgetfulness, confusion, getting lost, trouble thinking, drowsiness, trouble staying awake (somnolence), word finding problems, seeing objects or hearing things that are not there (hallucinations), or a change in mood or behavior.

Skin sensitivity to sunlight (photosensitivity). Your skin may be sensitive to the sun or other forms of light (photosensitivity) during treatment with AYVAKIT. Avoid or limit exposure to direct sunlight, sunlamps, and other sources of ultraviolet radiation during treatment and for 1 week after stopping treatment with AYVAKIT. Use sunscreen or wear clothes that cover your skin if you need to be out in the sun.

Before taking AYVAKIT, tell your healthcare provider about all of your medical conditions, including if you:

  • history of bulging or weakening of a blood vessel wall (aneurysm) or bleeding in your brain
  • have a history of stroke within the last year
  • have low platelet counts
  • have or have had liver problems
  • are pregnant or plan to become pregnant. AYVAKIT can cause harm to your unborn baby
  • Females who are able to become pregnant: Your healthcare provider should do a pregnancy test before you start AYVAKIT. You should use effective birth control (contraception) during treatment with AYVAKIT and for 6 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with AYVAKIT.
  • Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment and for 6 weeks after the final dose of AYVAKIT.
  • are breastfeeding or plan to breastfeed. It is not known if AYVAKIT passes into your breast milk. Do not breastfeed during treatment with AYVAKIT and for at least 2 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. AYVAKIT may affect the way other medicines work, and certain other medicines may affect how AYVAKIT works. Especially tell your healthcare provider if you take estrogen-containing hormonal birth control or medicines that prevent blood clots.

Do not drive or operate hazardous machinery if you have confusion or trouble thinking during treatment with AYVAKIT.

The most common side effects of AYVAKIT in people with ISM include: swelling around your eyes, dizziness, swelling of your arms and legs, and flushing.

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with AYVAKIT if you develop certain side effects. AYVAKIT may cause fertility problems in females and males. Talk to your healthcare provider if this is a concern for you.

These are not all of the possible side effects of AYVAKIT. Call your doctor for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here to see the full Prescribing Information and Patient Information for AYVAKIT.

INDICATION & IMPORTANT SAFETY INFORMATION

AYVAKIT® (avapritinib) may cause serious side effects, including:

Cognitive effects. Cognitive side effects can happen during treatment with AYVAKIT and can be severe. Tell your healthcare provider if you develop any new or worsening cognitive symptoms including forgetfulness, confusion, getting lost, trouble thinking, drowsiness, trouble staying awake (somnolence),

INDICATION & IMPORTANT SAFETY INFORMATION

Warning: AYVAKIT® (avapritinib) may cause serious side effects, including cognitive effects, skin sensitivity to sunlight (photosensitivity), harm to your unborn baby.

INDICATION & IMPORTANT SAFETY INFORMATION

Warning: AYVAKIT® (avapritinib) may cause serious side effects, including cognitive effects, skin sensitivity to sunlight (photosensitivity), harm to your unborn baby.

INDICATION

WHAT IS AYVAKIT® (avapritinib)?

AYVAKIT® (avapritinib) is a prescription medicine used to treat adults with indolent systemic mastocytosis (ISM). AYVAKIT is not recommended in people with low platelet counts (less than 50 X 109/L). It is not known if AYVAKIT is safe and effective in children.

IMPORTANT SAFETY INFORMATION

AYVAKIT® (avapritinib) may cause serious side effects, including:

Cognitive effects. Cognitive side effects can happen during treatment with AYVAKIT and can be severe. Tell your healthcare provider if you develop any new or worsening cognitive symptoms including forgetfulness, confusion, getting lost, trouble thinking, drowsiness, trouble staying awake (somnolence), word finding problems, seeing objects or hearing things that are not there (hallucinations), or a change in mood or behavior.

Skin sensitivity to sunlight (photosensitivity). Your skin may be sensitive to the sun or other forms of light (photosensitivity) during treatment with AYVAKIT. Avoid or limit exposure to direct sunlight, sunlamps, and other sources of ultraviolet radiation during treatment and for 1 week after stopping treatment with AYVAKIT. Use sunscreen or wear clothes that cover your skin if you need to be out in the sun.

Before taking AYVAKIT, tell your healthcare provider about all of your medical conditions, including if you:

  • history of bulging or weakening of a blood vessel wall (aneurysm) or bleeding in your brain
  • have a history of stroke within the last year
  • have low platelet counts
  • have or have had liver problems
  • are pregnant or plan to become pregnant. AYVAKIT can cause harm to your unborn baby
  • Females who are able to become pregnant: Your healthcare provider should do a pregnancy test before you start AYVAKIT. You should use effective birth control (contraception) during treatment with AYVAKIT and for 6 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with AYVAKIT.
  • Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment and for 6 weeks after the final dose of AYVAKIT.
  • are breastfeeding or plan to breastfeed. It is not known if AYVAKIT passes into your breast milk. Do not breastfeed during treatment with AYVAKIT and for at least 2 weeks after the final dose of AYVAKIT. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. AYVAKIT may affect the way other medicines work, and certain other medicines may affect how AYVAKIT works. Especially tell your healthcare provider if you take estrogen-containing hormonal birth control or medicines that prevent blood clots.

Do not drive or operate hazardous machinery if you have confusion or trouble thinking during treatment with AYVAKIT.

The most common side effects of AYVAKIT in people with ISM include: swelling around your eyes, dizziness, swelling of your arms and legs, and flushing.

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with AYVAKIT if you develop certain side effects. AYVAKIT may cause fertility problems in females and males. Talk to your healthcare provider if this is a concern for you.

These are not all of the possible side effects of AYVAKIT. Call your doctor for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here to see the full Prescribing Information and Patient Information for AYVAKIT.